Healthtech and biotech ventures working at the interface with pharma R&D apply once a year to this 12-week hybrid programme, which opens and closes with in-person events in Basel and runs mentoring and cohort sessions online in between. Participation is equity-free and fee-free, so the programme itself writes no cheque. Separately, up to three startups from each cohort go on to DayOne NEXT and can receive CHF 50,000 in non-dilutive funding plus support and desk space.
Investment
Not disclosed
Equity taken
0% (Like 88% of Europe & C. Asia · Like 79% globally)
Duration
12 weeks (Shorter than Europe & C. Asia median 26 wks · Shorter than global median 20 wks)